Cardio Diagnostics (CDIO) vs ImmuCell (ICCC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
ImmuCell is the larger company by market cap ($88.0 million vs $5.8 million), about 15.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CDIO | ICCC |
|---|---|---|
| Share price | $1.96 | $9.69 |
| Market cap | $5.80M | $88.01M |
| 1-day change | -2.00% | -2.81% |
| YTD return | — | +57.56% |
| 1-year return | — | +50.23% |
| 5-year return | — | +4.42% |
| P/E ratio (TTM) | — | 138.43 |
| EPS (TTM) | $-2.91 | $0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.91 | $12.10 |
| 52-week low | $0.97 | $4.52 |
| Distance from 52-week high | -75.22% | -19.92% |
| Average volume | 55.78K | 23.16K |
| Shares outstanding | 2.96M | 9.08M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ImmuCell is about 15.2 times larger than Cardio Diagnostics by market value ($88.01M vs $5.80M).
CDIO vs ICCC FAQ
Which is bigger, Cardio Diagnostics or ImmuCell?
ImmuCell (ICCC) is larger, with a market capitalization of $88.01M compared with $5.80M for Cardio Diagnostics (CDIO).
Are Cardio Diagnostics and ImmuCell in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.